Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Plant Breeding and Biotechnology01:59

Plant Breeding and Biotechnology

Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
Synthetic Biology02:55

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
The Central Dogma01:20

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Recombinant DNA01:09

Recombinant DNA

Overview
Recombinant DNA01:09

Recombinant DNA

Overview

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

From bench to business: career opportunities in biotechnology.

Nature biotechnology·1997
Same author

The changing dynamics of strategic alliances between US biotechnology firms and Japanese corporations and universities.

Trends in biotechnology·1994
Same author

Finding what you need to know in the biotechnology business.

Trends in biotechnology·1994
Same author

Blood brothers. Alliances between biotechnology and pharmaceutical companies in the U.S.

Bio/technology (Nature Publishing Company)·1993
Same author

Away from home: U.S. sites of European and Japanese biotech R&D.

Bio/technology (Nature Publishing Company)·1992
Same author

Tracking trends in U.S. biotechnology.

Bio/technology (Nature Publishing Company)·1991

関連する実験動画

Updated: Jul 11, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

ヨーロッパにおけるバイオテクノロジー

M D Dibner

    Science (New York, N.Y.)
    |June 13, 1986
    PubMed
    まとめ

    欧州経済共同体諸国は,バイオテクノロジーの商業化を促進し,米国の企業数と政府支出に匹敵しています. ヨーロッパは基礎研究よりも産業と大学の関係を優先し,米国の戦略とは異なる.

    科学分野:

    • バイオテクノロジーの商業化戦略
    • バイオテクノロジー部門の比較分析

    背景:

    • 欧州経済共同体 (EEC) の諸国は,バイオテクノロジーの商業化に向けた努力を強化した.
    • EECのバイオテクノロジーイニシアチブは,企業数と政府投資で米国と競合する.
    • ヨーロッパと米国のバイオテクノロジーの事業と投資の間で大きな重複がある.

    研究 の 目的:

    • EEC諸国と米国におけるバイオテクノロジーの商業化戦略と取り組みを検証,比較する.
    • 欧州と米国のバイオテクノロジー開発における政府の重点における重要な違いを強調する.

    主な方法:

    • バイオテクノロジーにおける政府支出と企業の関与の比較分析.
    • 産業大学間の協力と産業プロジェクト支援の検討.
    • 欧州企業による米国での事業の規模を評価し,その逆も同様である.

    主要な成果:

    • 欧州のバイオテクノロジーの取り組みは,規模 (企業と資金調達) で米国の取り組みに匹敵します.
    • 欧州の政府は,産業と大学の連携や産業プロジェクトを支援することに重点を置いています.
    • 米国は,バイオテクノロジーにおける基礎研究の支援に,より重点を置いています.

    さらに関連する動画

    The MultiBac Protein Complex Production Platform at the EMBL
    13:51

    The MultiBac Protein Complex Production Platform at the EMBL

    Published on: July 11, 2013

    Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure
    05:34

    Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure

    Published on: December 13, 2024

    関連する実験動画

    Last Updated: Jul 11, 2026

    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
    08:01

    Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

    Published on: November 30, 2022

    The MultiBac Protein Complex Production Platform at the EMBL
    13:51

    The MultiBac Protein Complex Production Platform at the EMBL

    Published on: July 11, 2013

    Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure
    05:34

    Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure

    Published on: December 13, 2024

    結論:

    • 欧州のバイオテクノロジーの商業化は,米国と比較して,重要で成長するセクターです.
    • 異なる政府の支援戦略は,ヨーロッパにおけるバイオテクノロジーの発展の軌跡と,米国における発展の軌跡に影響を与える可能性があります.
    • 欧州と米国のバイオテクノロジー市場の相互接続性は,世界のバイオテクノロジー動向の全体的な見方を必要としています.